Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case–control study
Open Access
- 8 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cardiovascular Disorders
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12872-021-01893-y
Abstract
Background Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical roles in transcription regulation, and their circulating levels were reported to have potential as clinical biomarkers. Methods In total, 93 coronary stent-implanted patients without pregnancy, liver or renal dysfunction, malignancy, hemophilia, or autoimmune diseases were recruited in this clinical study. All recruited participants were divided into an ISR group (n = 45) and a non-ISR group (n = 48) based on their restenotic status as confirmed by cardiologists at the first follow-up visit (6 months after surgery). Blood samples of all participants were harvested to measure circulating levels of miRNA candidates (miR-132, miR-142-5p, miR-15b, miR-24-2, and miR-424) to evaluate whether these circulating miRNAs can be applied as predictive biomarkers of ISR. Results Our data indicated that circulating levels of miR-142-5p were significantly higher in the ISR population, and results from the receiver operating characteristic (ROC) curve analysis also demonstrated superior discriminatory ability of miR-142-5p in predicting patients’ restenotic status. In addition, circulating levels of miR-15b, miR-24-2, and miR-424 had differential expressions in participants with diabetes, hyperlipidemia, and hypertension, respectively. Conclusions The current study revealed that the circulating level of miR-142-5p has potential application as a clinical biomarker for predicting the development of ISR in stent-implanted patients.Keywords
This publication has 44 references indexed in Scilit:
- Identification of Sensitive Serum microRNA Biomarkers for Radiation BiodosimetryPLOS ONE, 2013
- Extracellular microRNA: A new source of biomarkersMutation Research, 2011
- Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology, 2011
- MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2011
- The role of microRNAs in hematopoietic stem cell and leukemic stem cell functionTherapeutic Advances in Hematology, 2011
- MicroRNAs: Synthesis, mechanism, function, and recent clinical trialsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetesCardiovascular Diabetology, 2007
- Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary InterventionsCirculation, 2005
- Tumor necrosis factor‐α plays an important role in restenosis developmentThe FASEB Journal, 2005
- Diabetes and Cardiovascular Disease Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart AssociationCirculation, 2002